Market Cap 166.23M
Revenue (ttm) 154.90M
Net Income (ttm) -20.20M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13.04%
Debt to Equity Ratio 7.53
Volume 2,114,900
Avg Vol 1,725,970
Day's Range N/A - N/A
Shares Out 188.54M
Stochastic %K 0%
Beta 1.26
Analysts Sell
Price Target $4.50

Company Profile

Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed na...

Industry: Biotechnology
Sector: Healthcare
Phone: (858) 251-4400
Address:
100 Regency Forest Drive, Suite 300, Cary, United States
Shooter40
Shooter40 Mar. 15 at 11:23 PM
$HRTX zyn is trending very well. march quarter could be over $14 million, or 70% growth from last year. apo should see another 100% growth quarter from the previous year cin needs to tread water and be flat. if that can happen, this stock will move. thanks braddog for the numbers!
0 · Reply
Braddog
Braddog Mar. 15 at 10:35 PM
$HRTX Cinvanti is worrying me!
1 · Reply
Braddog
Braddog Mar. 15 at 10:14 PM
$HRTX Aponvie and Cinvanti
0 · Reply
Braddog
Braddog Mar. 15 at 10:13 PM
$HRTX Zynrelef
0 · Reply
jacksonjohn750
jacksonjohn750 Mar. 15 at 12:01 PM
$HRTX we should be getting the feb numbers soon.. looking forward to that
0 · Reply
EMINENZ
EMINENZ Mar. 13 at 8:28 PM
$HRTX ZYN & APO gonna bring inn 800M combined until 2030 imo. Just need to hold strong.
0 · Reply
slayer2408
slayer2408 Mar. 13 at 8:21 PM
$HRTX to the moon
0 · Reply
ShelbyRG
ShelbyRG Mar. 13 at 8:12 PM
$HRTX I bought
0 · Reply
chance111
chance111 Mar. 13 at 7:11 PM
$HRTX I keep getting messages on my computer screen that this site is dangerous to my computer. It is happening more and more. Is anyone else getting this warning?
1 · Reply
SpaceForceOne
SpaceForceOne Mar. 13 at 6:39 PM
$HRTX A RS?!? Milans - Sdawg said notice , not otherwise. Hard to argue anything else at this point. I agree with him/her. A Nasdaq non compliant- delisting notice is very possible if Heron spends another couple / few weeks sub $1 at the close consecutively . 30 days and you are notified. Friday 3/6/26 was day 1 at sub $1 as I recall. Now, Heron would have 180 days following to correct course. I am almost certain in that time frame they will find enough footing above $1 to stave off such drastic measures . Which would include 2 more ER’s posted. Heron is majority institution owned and acutely aware of what needs to happen. However unlikely - if Heron were to be forced to RS in order to avoid OTC . Then any retail investor in their right mind would liquidate , take the L , and move on.
0 · Reply
Latest News on HRTX
Heron: Near The Bottom Of A Trading Range Despite Positives

Feb 18, 2026, 10:28 AM EST - 25 days ago

Heron: Near The Bottom Of A Trading Range Despite Positives


Heron Therapeutics, Inc. (HRTX) Q1 2025 Earnings Call Transcript

May 6, 2025, 11:38 AM EDT - 11 months ago

Heron Therapeutics, Inc. (HRTX) Q1 2025 Earnings Call Transcript


U.S. District Court Upholds Validity of CINVANTI® Patents

Dec 3, 2024, 4:36 PM EST - 1 year ago

U.S. District Court Upholds Validity of CINVANTI® Patents


Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain

Apr 16, 2024, 4:24 PM EDT - 2 years ago

Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain


Heron Therapeutics, Inc. (HRTX) Q4 2023 Earnings Call Transcript

Mar 12, 2024, 10:35 PM EDT - 2 years ago

Heron Therapeutics, Inc. (HRTX) Q4 2023 Earnings Call Transcript


Shooter40
Shooter40 Mar. 15 at 11:23 PM
$HRTX zyn is trending very well. march quarter could be over $14 million, or 70% growth from last year. apo should see another 100% growth quarter from the previous year cin needs to tread water and be flat. if that can happen, this stock will move. thanks braddog for the numbers!
0 · Reply
Braddog
Braddog Mar. 15 at 10:35 PM
$HRTX Cinvanti is worrying me!
1 · Reply
Braddog
Braddog Mar. 15 at 10:14 PM
$HRTX Aponvie and Cinvanti
0 · Reply
Braddog
Braddog Mar. 15 at 10:13 PM
$HRTX Zynrelef
0 · Reply
jacksonjohn750
jacksonjohn750 Mar. 15 at 12:01 PM
$HRTX we should be getting the feb numbers soon.. looking forward to that
0 · Reply
EMINENZ
EMINENZ Mar. 13 at 8:28 PM
$HRTX ZYN & APO gonna bring inn 800M combined until 2030 imo. Just need to hold strong.
0 · Reply
slayer2408
slayer2408 Mar. 13 at 8:21 PM
$HRTX to the moon
0 · Reply
ShelbyRG
ShelbyRG Mar. 13 at 8:12 PM
$HRTX I bought
0 · Reply
chance111
chance111 Mar. 13 at 7:11 PM
$HRTX I keep getting messages on my computer screen that this site is dangerous to my computer. It is happening more and more. Is anyone else getting this warning?
1 · Reply
SpaceForceOne
SpaceForceOne Mar. 13 at 6:39 PM
$HRTX A RS?!? Milans - Sdawg said notice , not otherwise. Hard to argue anything else at this point. I agree with him/her. A Nasdaq non compliant- delisting notice is very possible if Heron spends another couple / few weeks sub $1 at the close consecutively . 30 days and you are notified. Friday 3/6/26 was day 1 at sub $1 as I recall. Now, Heron would have 180 days following to correct course. I am almost certain in that time frame they will find enough footing above $1 to stave off such drastic measures . Which would include 2 more ER’s posted. Heron is majority institution owned and acutely aware of what needs to happen. However unlikely - if Heron were to be forced to RS in order to avoid OTC . Then any retail investor in their right mind would liquidate , take the L , and move on.
0 · Reply
CliffordCapital
CliffordCapital Mar. 13 at 6:18 PM
$HRTX 83% tute ownership with new heights in Q4 25. This doesn‘t look like a dead company.
0 · Reply
CliffordCapital
CliffordCapital Mar. 13 at 6:15 PM
$HRTX I bought into this company January 9th after they announced preliminary FY25 results. Stock spiked and caught my attention. I bought in at 1.51$… now down -40% and nothing bad has happened… this crashed 40% for no reason… in fact it initially pumped when good numbers where reported early January.. I don‘t get this selloff lol.
1 · Reply
Sdwg
Sdwg Mar. 13 at 5:41 PM
$HRTX delisting notice soon IMO, what the shorts want...
1 · Reply
CliffordCapital
CliffordCapital Mar. 13 at 4:29 PM
$HRTX 168M MC… 180M sales this year with 15% growth YoY… 40M cash on hand…. Yes they have 180M debt but that is still insanely undervalued.. wow. 😮
1 · Reply
Stock_Value1
Stock_Value1 Mar. 13 at 4:08 PM
$HRTX $HRTX $HRTX I sent an email to Heron expressing my concerns over the apparent lack of support for shareholders by management. I suggested a PR regarding sales updates and/or an insider purchase as possible ways to show support. It will likely fall on deaf ears. Investor relations email address is: mailto:[email protected] if others also want to send an express their concerns to management.
2 · Reply
Braddog
Braddog Mar. 13 at 4:01 PM
$HRTX $0.50 here we come
1 · Reply
cheating_stock_investor
cheating_stock_investor Mar. 13 at 3:28 PM
$HRTX any barry quart fans left here at the heron board come check out $CNTB Hes gonna bring this double digits shortly.
0 · Reply
Braddog
Braddog Mar. 13 at 3:12 PM
$HRTX This is beyond horrible This just Fing sucks Maybe this is being manipulated down so that the big investors can lower their dollar cost average. As they know that Heron has a minimal chance of getting above $2 or $3 or something like that
1 · Reply
Shooter40
Shooter40 Mar. 13 at 2:32 PM
$HRTX why is there zero insider buying????? CC was so enthusiastic on the call, but they don’t step up and buy in the open market. Is he that out of touch with investors???
1 · Reply
milans100
milans100 Mar. 13 at 1:23 PM
$HRTX I believe CC had made the point in one of the CC’s that the main benefit of PFS will be the complete elimination of a training step in the sales process. Even with VAN, there has to be a special training that has to be delivered, which slows down the sales/adoption process and puts more work on the already thin sales team. PFS should eliminate these two friction points. As far as I am concerned, all moot. PFS will happen after $HRTX acquisition in Q2-Q3 :-)
3 · Reply
Braddog
Braddog Mar. 13 at 1:17 PM
$HRTX IMHO Adoption of Zyn has nothing to do with the VAN or PFS. The VAN has removed that barrier to adoption! Education is the best way to get Zyn adopted by MDs in Hospitals and ASCs.
0 · Reply
keypatience
keypatience Mar. 12 at 9:44 PM
$HRTX Fair point. My original wording was too absolute. PFS does not eliminate every barrier. It does not solve cost pressure, block-use limitations, label constraints, or physician preference. My point was narrower: if Heron introduced VAN to simplify prep and reduce withdrawal time, and is still pushing a prefilled syringe, then management itself clearly sees ease of use and workflow as real adoption levers.
1 · Reply